As of 2025-07-12, the Relative Valuation of Gemina Laboratories Ltd (GLAB.CN) is - CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.74 CAD, the upside of Gemina Laboratories Ltd based on Relative Valuation is -.
The range of the Relative Valuation is - CAD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | - | - |
| Forward P/E multiples | - | - |
| Fair Price | - | - |
| Upside | - | - |
| Date | P/E |
| 2025-07-09 | -11.25 |
| 2025-07-04 | -11.71 |
| 2025-07-03 | -10.19 |
| 2025-07-02 | -10.64 |
| 2025-06-27 | -11.86 |
| 2025-06-26 | -11.86 |
| 2025-06-16 | -12.31 |
| 2025-06-12 | -12.92 |
| 2025-06-11 | -12.92 |
| 2025-06-10 | -12.92 |
| 2025-06-09 | -11.55 |
| 2025-06-04 | -12.92 |
| 2025-06-03 | -14.75 |
| 2025-05-21 | -15.51 |
| 2025-05-20 | -15.66 |
| 2025-05-16 | -15.66 |
| 2025-05-15 | -13.53 |
| 2025-05-14 | -13.53 |
| 2025-05-12 | -13.38 |
| 2025-05-09 | -10.34 |
| 2025-05-08 | -15.81 |
| 2025-05-07 | -15.96 |
| 2025-05-06 | -15.96 |
| 2025-05-05 | -15.96 |
| 2025-05-02 | -15.96 |
| 2025-04-29 | -15.35 |
| 2025-04-24 | -15.96 |
| 2025-04-22 | -15.20 |
| 2025-04-21 | -15.20 |
| 2025-04-14 | -17.48 |